Your Search Returned 6 tagged news reports
N.J. — Drug developer Watson Pharmaceuticals Inc. said Tuesday it is offering $850 million in a mix of senior notes. The company is offering $450 million of 5 percent senior notes due 2014 and $400 million of 6.125 percent senior notes due 2019. Watson...
Tags: Moody's Investors Service, Watson Pharmaceuticals Inc., senior note
Watson Pharmaceuticals Inc. said Monday Chief Financial Officer Mark W...Todd Joyce, vice president, controller and treasurer, has been appointed acting principal financial officer, the company said. Shares of Watson Pharmaceuticals closed up 42 cents,...
Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive...Duramed has exclusive rights from Barr Pharmaceuticals to sell an over-the-counter...
Watson Pharmaceuticals says it is buying generic drug maker Arrow Group for $1.75 billion in cash and stock. Watson of Morristown, N.J., says it is getting a promising drug candidate pipeline and access to new markets in the deal. It says the combined...
Tags: Watson Pharmaceuticals Inc., Arrow Group, combined company, buy arrow
Memory is already a partner with Roche on a midstage drug candidate aimed at treating Alzheimer's disease and schizophrenia, along with an early-stage compound aimed at Alzheimer's disease. "The innovative work carried out by the scientists at Memory...
Tags: Memory Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Roche Signs Definitive Agreement, Watson Pharmaceuticals Inc.
Prostate drug is effective, safe Watson Pharmaceuticals Inc. on Monday reported results from four late stage trials of its drug candidate silodosin, saying the drug was well tolerated and reduced symptoms of prostate enlargement. Watson presented results...